Tech Company Financing Transactions
Senti Biosciences Funding Round
Senti Biosciences closed a $53 million Series A venture capital round on 2/28/2018. Investors included New Enterprise Associates, 8VC and Allen & Company.
Transaction Overview
New Enterprise Associates (Lead Investor) (Ed Mathers)
8VC (Alex Kolicich)
Company Information
San Francisco, CA 94080
USA
Management Team
Browse more venture capital transactions:
Prev: 2/28/2018: CyberX venture capital transaction
Next: 2/28/2018: SteroTherapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs